To follow up this question, we used the longitudinal NACC data and found that ACE inhibitors were associated with lower incidence of AD in the absence of ApoE4, but there was no such association in the presence of ApoE4 (Table 2 and Fig. 2). Here, APOE is linked to Alzheimer disease.